Mutations

SORL1 T2160M

Overview

Clinical Phenotype: Alzheimer's Disease
Position: (GRCh38/hg38):Chr11:121627669 C>T
Position: (GRCh37/hg19):Chr11:121498378 C>T
dbSNP ID: rs372203239
Coding/Non-Coding: Coding
DNA Change: Substitution
Expected Protein Consequence: Missense
Codon Change: ACG to ATG
Reference Isoform: SORL1 Isoform 1 (2214 aa)
Genomic Region: Exon 47

Findings

In a Dutch sample of 640 Alzheimer’s cases and 1268 controls, one 76-year-old control was found to be a heterozygous carrier of this variant. No additional carriers were found among 1255 cases and 1938 controls from the European Early-Onset Dementia Consortium dataset (Holstege et al., 2017).

Another carrier—a late-onset AD case—was found in a dataset from the Alzheimer Disease Exome Sequencing France (ADESFR) project containing 927 late-onset Alzheimer’s cases, 852 early-onset cases, and 1273 controls (Campion et al., 2019).

In a study that included 15,808 Alzheimer’s cases and 16,097 control subjects from multiple European and American cohorts, including the ADESFR and Dutch cohorts cited above, this allele was observed three times—once among the AD cases and twice among the controls (Holstege et al., 2022).

The T2160M variant is classified as likely benign by the criteria of Holstege et al. (Holstege et al., 2017).

Functional Consequences

The T2160M variant was predicted to be tolerated by SIFT and benign by PolyPhen-2, but deleterious by Mutation Taster (Campion et al., 2019).

Last Updated: 18 Jul 2024

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

  1. . Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet. 2017 Aug;25(8):973-981. Epub 2017 May 24 PubMed.
  2. . SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data. Acta Neuropathol. 2019 Aug;138(2):173-186. Epub 2019 Mar 25 PubMed.
  3. . Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease. Nat Genet. 2022 Dec;54(12):1786-1794. Epub 2022 Nov 21 PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet. 2017 Aug;25(8):973-981. Epub 2017 May 24 PubMed.

Other mutations at this position

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.

AlzAntibodiesAlzBiomarkerAlzRiskBrain BanksGeneticsAlzGeneHEXMutationsProtocolsResearch ModelsTherapeutics